Our Team is

Your Team

Our Team Is Your Team

Our core team has been working together for well over a decade. We’ve developed a unique ability to cultivate winning investment themes while keeping watch over the landscape of healthcare in North America. We are proud to help top-tier biotherapeutic and medical device companies realize their vision.

Investment Team

Peter van der Velden, MBA, MSc.

Managing General Partner

With 28 years of investment and operating experience, Peter has participated in building companies from start-up through to expansion in the life sciences, information technology, and consumer... Read More

Gerry Brunk, MBA

Managing Director

With over 28 years of investment, consulting and entrepreneurial experience in the health care industry, Gerry has helped build life sciences companies at all stages of development. He focuses on... Read More

Beni Rovinski, Ph.D.

Managing Director

With over 30 years of investment, operational, managerial and research experience in the healthcare industry, Beni has helped build life sciences companies at all stages of development. Known both as... Read More

Daniel Hetu, M.D., MBA

Managing Director

With over 20 years of investment banking, corporate development, and licensing and investment experience, Daniel has been involved with life sciences companies at all stages of development in North... Read More

Jacki Jenuth, Ph.D.


With over 20 years of life science, IT and business development executive-level experience, Jacki is a key member of the senior management team with responsibilities that include financial analysis,... Read More

Brent Norton, M.D., MBA, ICD.D

Venture Partner

With over 25 years of experience in the Life Science industry, Dr. Norton uses his cross functional knowledge to develop strategy, raise capital and build important relationships in the academic and... Read More

Richard Glickman, L.L.D. (Hon)

Venture Partner

Dr. Richard M. Glickman is one of Canada’s best known and most successful healthcare entrepreneurs. He is a co-founder and the chairman of Aurinia Pharma Corp., the founding Chairman of the Board... Read More

Lu Han, Ph.D.

Director, Business Development Asia Pacific

Lu is passionate about helping entrepreneurs achieving their goals being a co-founder of a start-up company prior to joining Lumira Ventures in late 2014 as an analyst and later promoted to Director... Read More

Baye Galligan, MA, HBA


Baye Galligan joined Lumira Ventures' Toronto office as an analyst in 2017. She focuses on business and technical due diligence and analyses of investment opportunities, as well as financial analysis... Read More

Nikhil Thatte


Nikhil joined Lumira Ventures in March 2019. Having spent his entire career in the healthcare industry, he is keen to use his broad expertise to help inventors and entrepreneurs bring clinically... Read More

Operations Team

Dahlia Abbott

Accounting / Office Manager

With over 25 years of financial and office management experience, Dahlia is a key member of the operations team responsible for the day-to-day operational and financial administration of Lumira... Read More

Vasco Larcina, CPA

VP Finance

Contributing over 20 years of senior financial management and audit experience, Vasco is a key member of senior management working closely with our investment team, external auditors and other... Read More

Jennifer Schram

Director of Operations and Communications

Jennifer joined Lumira in March 2019. As Director of Operations and Communications, Jennifer will work with senior leadership to develop and implement new business initiatives, oversee non-investment... Read More

Advisory Board

John Gillard, Ph.D.

VP Product Development, Kalgene Pharmaceuticals

Dr. John W. Gillard sits on the advisory board of Lumira Ventures and is an adjunct Professor at McGill University, Faculty of Medicine and President of BioGill Consultants Inc. He is currently... Read More

Dr. Theodore Witek

Former President & CEO, Boehringer Ingelheim Canada (Retired) & CSO & Senior Vice President, Corporate Partnerships, Innoviva (formerly Theravance)

During Dr. Witek’s 31 year career with Boehringer Ingelheim he held various clinical research positions, including Director of Respiratory and Immunology Clinical Research and most recently he... Read More

Maurice R. Ferré, M.D.

Former President and Chief Executive Officer, MAKO Surgical Corp.

Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in... Read More